Methotrexate Hydrate is a pharmaceutical-grade antineoplastic antimetabolite that functions as a dihydrofolate reductase inhibitor. Clinically, this compound is employed in the treatment of various malignancies,… Read more
Methotrexate Hydrate is a pharmaceutical-grade antineoplastic antimetabolite that functions as a dihydrofolate reductase inhibitor. Clinically, this compound is employed in the treatment of various malignancies, as well as severe psoriasis, rheumatoid arthritis, and juvenile rheumatoid arthritis. The category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient itself, alongside related impurities and degradation products such as 2-aminopteridin-6-yl methanol and 7-(bromomethyl)pteridine-2,4-diamine hydrobromide. These high-quality standards are essential for analytical testing, impurity profiling, and method validation within pharmaceutical quality control laboratories. By utilizing these characterized reference materials, researchers can accurately identify and quantify potential impurities, ensuring the stability and regulatory compliance of drug formulations throughout the development and manufacturing processes.